Nintedanib plus mFOLFOX6 as second-line treatment of metastatic, chemorefractory colorectal cancer: the randomised, placebo-controlled, phase II TRICC-C study (AIO-KRK-0111)
by Ettrich, Thomas J. (Author)
, Perkhofer, Lukas (Author)
, Decker, Thomas (Author)
, Hofheinz, Ralf-Dieter (Author)
, Heinemann, Volker (Author)
, Hoffmann, Thomas (Author)
, Hebart, Holger F. (Author)
, Herrmann, Thomas (Author)
, Hannig, Carla V. (Author)
, Büchner-Steudel, Petra (Author)
, Güthle, Melanie (Author)
, Hermann, Patrick C. (Author)
, Berger, Andreas (Author)
, Seufferlein, Thomas (Author)
,
Call Number:
Loading…
Located:
Loading…
Article (Journal)
Online Resource